AKAN Company Profile and Key Details

AKAN has shown weak momentum, losing -31.56% over the past week and -84.28% over the past quarter, though year-to-date performance is down -21.28%. Short-term trend indicators are bullishly aligned (SMA20 -8.04%, SMA50 -49.15%, SMA200 -92.46%). The stock’s 14-day RSI is 35.39 (weak momentum), while the ATR of 0.21 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -98.02% below its high and over 13.41% above its low. Average 10-day trading volume of 5.64 million shares is significantly above the 3-month average of 714.41 thousand, indicating heightened recent market interest.

Akanda Corp. generated EPS of -$22.61 over the past year. Five-year average earnings growth is 36.07%.

Akanda Corp. has 534.42 thousand shares outstanding. The public float is 32.17 thousand shares, elevated short interest at 4.61% of float. This equals 24.61 thousand shares. The short ratio is 0.3 days. Institutional investors hold 0.01% of the float. Insiders own 0.8%. Over the past six months, insider transactions show balanced activity. They sold 7.87 thousand shares across 1 transactions.

Akanda Corp. (NASDAQ:AKAN) closed at $10.21 USD, gaining $6.96 (214.15%) from the previous close of $3.25. The stock is currently mid-range between its 52-week high and low $2.30 and $209.23. With a market capitalization of about $330.46 thousand, Akanda Corp. is classified as a micro-cap and shows higher-than-market volatility (beta ~1.73). Key stats such as the average daily volume over the past year has been around 761.57 thousand shares, trading with heavier-than-usual volume. Headquartered in New Romney, ON, Akanda Corp. operates in the Healthcare sector and the Drug Manufacturers - Specialty & Generic industry. Led by CEO Katharyn Field, the company employs approximately 46 people and listed since March 15, 2022. Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products in the United Kingdom, Lesotho, and internationally.

Akanda Corp. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $4.01. This means the shares are trading above this model’s fair value.

Akanda Corp. trades at a P/E ratio of -0.05, slightly below the S&P 500 average, with a price-to-sales ratio of 0.29 and a price-to-book ratio of 0.03 suggesting the stock is closer to book value. The P/FCF stands at -0.04, also above market averages.

Our AI price prediction model suggests that Akanda Corp. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -31.73%, with price expected at $6.97 by May 06, 2026, within a range of $5.95 to $8.00 3-Month Outlook: Projected fall of -91.77%, reaching $0.84 by July 21, 2026, with a range of $0.00 to $2.83. 1-Year Outlook: Projected loss of -100.0%, with price at $0.00 by April 22, 2027, within a range of $0.00 to $131.41.

Akanda Corp. (NASDAQ:AKAN) shares are down -21.28% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Akanda Corp. trading at a premium to the broader market with a P/E of -0.05. Our AI forecast model points to short-term weakness (-31.73% over two weeks), a medium-term fall (-91.77% over three months), and a longer-term loss (-100.0% over one year), with expected trading ranges indicating moderate volatility.